BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28259289)

  • 1. Proton Pump Inhibitors in cancer patients: How useful they are? A review of the most common indications for their use.
    Numico G; Fusco V; Franco P; Roila F
    Crit Rev Oncol Hematol; 2017 Mar; 111():144-151. PubMed ID: 28259289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal.
    Savarino V; Dulbecco P; de Bortoli N; Ottonello A; Savarino E
    Eur J Intern Med; 2017 Jan; 37():19-24. PubMed ID: 27784575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug repurposing for anticancer therapies. A lesson from proton pump inhibitors.
    Spugnini EP; Fais S
    Expert Opin Ther Pat; 2020 Jan; 30(1):15-25. PubMed ID: 31847622
    [No Abstract]   [Full Text] [Related]  

  • 4. Repositioning of proton pump inhibitors in cancer therapy.
    Lu ZN; Tian B; Guo XL
    Cancer Chemother Pharmacol; 2017 Nov; 80(5):925-937. PubMed ID: 28861639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors.
    Lazzaroni M; Porro GB
    Drugs; 2009; 69(1):51-69. PubMed ID: 19192936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure.
    Raoul JL; Moreau-Bachelard C; Gilabert M; Edeline J; Frénel JS
    ESMO Open; 2023 Feb; 8(1):100880. PubMed ID: 36764092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: a systematic review and meta-analysis of randomized controlled trials.
    Wang CH; Ma MH; Chou HC; Yen ZS; Yang CW; Fang CC; Chen SC
    Arch Intern Med; 2010 May; 170(9):751-8. PubMed ID: 20458081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders.
    Richardson P; Hawkey CJ; Stack WA
    Drugs; 1998 Sep; 56(3):307-35. PubMed ID: 9777309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety.
    Savarino V; Di Mario F; Scarpignato C
    Pharmacol Res; 2009 Mar; 59(3):135-53. PubMed ID: 18977444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism.
    Fais S
    J Intern Med; 2010 May; 267(5):515-25. PubMed ID: 20433578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of proton pump inhibitors in an Italian hospital: focus on oncologic and critical non-ICU patients.
    Meli M; Raffa MP; Malta R; Morreale I; Aprea L; D'Alessandro N
    Int J Clin Pharm; 2015 Dec; 37(6):1152-61. PubMed ID: 26319396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.
    Robinson M; Horn J
    Drugs; 2003; 63(24):2739-54. PubMed ID: 14664653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.
    van der Pol RJ; Smits MJ; van Wijk MP; Omari TI; Tabbers MM; Benninga MA
    Pediatrics; 2011 May; 127(5):925-35. PubMed ID: 21464183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors as also inhibitors of atrial fibrillation.
    Lin K; Chen X; Zhang L; Wang Y; Shan Z
    Eur J Pharmacol; 2013 Oct; 718(1-3):435-40. PubMed ID: 23973848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
    Kwok CS; Jeevanantham V; Dawn B; Loke YK
    Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of prophylactic proton pump inhibitors for prevention of non-steroidal anti inflammatory drugs associated gastric and duodenal ulcers in elderly.
    Kheiri B; Mabrouk A; Ahmed I; Khan H; Sheikh AS
    Qual Prim Care; 2014; 22(6):282-4. PubMed ID: 25887654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Updating in prescription of proton pump inhibitors. What to do and what not to do].
    Saiz Ladera GM; Pejenaute Labari ME; García Pascual JN
    Semergen; 2021; 47(4):267-279. PubMed ID: 33223372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it safe to use a proton pump inhibitor with clopidogrel?
    Chow CK; Moayyedi P; Devereaux PJ
    Pol Arch Med Wewn; 2009 Sep; 119(9):564-8. PubMed ID: 19776701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of use of proton pump inhibitors in Greece.
    Ntaios G; Chatzinikolaou A; Kaiafa G; Savopoulos C; Hatzitolios A; Karamitsos D
    Eur J Intern Med; 2009 Mar; 20(2):171-3. PubMed ID: 19327607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.